Project Number 1R41AG081124-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for The development of a multifunctional nanoenzyme for AD treatment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator XU, PEISHENG Principal Investigator First Name PEISHENG Principal Investigator Last Name XU Awardee Organization ACEPRE, LLC Awardee State South Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-317: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $299,628 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
